Search Results 2581-2590 of 17367 for Selective mutism
The purpose of this study is to evaluate a novel direct single DNA molecule optical imaging system (Bionano) for the FSHD diagnosis. Participation eligibility.
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...
About this study. Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.
About this study. This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in ...
TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...
About this study. The potential role of Small bowel bacterial overgrowth (SBBO) in weight loss occurring in patients with PD has not previously been ...
About this study. RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in ...
The purpose of this study is to evaluate the postoperative outcomes of hamate-to-scaphoid transfer in a series of patients with collection of both retrospective ...
About this study. RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin, work in different ...
The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!